Clinical Value of Neutrophil Gelatinase-Associated Lipocalin as a Non-Invasive Biomarker for Intestinal Ulcer in Behçet’s Syndrome: A Pilot Study
= 0.015), with superior predictive performance over conventional inflammatory markers. In conclusion, fecal NGAL serves as a non-invasive and promising biomarker for risk stratification of intestinal involvement in BS patients. Further large-scale prospective studies are required to verify these preliminary results.
Authors
- Jing‐fen Ye (ORCID: https://orcid.org/0000-0001-9688-5568)
- Jian‐Long Guan (ORCID: https://orcid.org/0000-0002-6481-480X)
- Jian-Fei Cai (ORCID: https://orcid.org/0000-0001-8528-6690)
- Yuxin Liu (ORCID: https://orcid.org/0000-0001-8191-1145)
- Yixuan Zhang (ORCID: https://orcid.org/0000-0001-7317-7235)
- Liyang Zhang (ORCID: https://orcid.org/0000-0002-4054-1667)
- J. H. Zou
- Dan Hu
Institutions
- Fudan University (CN)
- Huadong Hospital (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-03-31
- DOI
- https://doi.org/10.3390/ijms27073152
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission